Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1644-1648, April 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmerman, R. J.
Right arrow Articles by Leadon, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmerman, R. J.
Right arrow Articles by Leadon, S. A.

Oxidative Damage in Murine Tumor Cells Treated in Vitro by Recombinant Human Tumor Necrosis Factor1

Robert J. Zimmerman2, Anthony Chan and Steven A. Leadon

Department of Pharmacology, CETUS Corporation, Emeryville, California 94608 [R. J. Z., A. C.], and Lawrence Berkeley Laboratory, University of California, Berkeley, California 94720 [S. A. L.]

Treatment of three murine tumor cell lines, L929, P388, and Pan-02, in vitro with recombinant human tumor necrosis factor (rhTNF) produced evidence of oxidative damage as measured by (a) increases in intracellular glutathione levels, (b) the formation of intracellular oxidized glutathione and (c) the formation of thymine glycols in DNA. L929, the most sensitive of the three cell lines to the cytotoxic activity of rhTNF, had the lowest total glutathione content and was observed to have the highest levels of oxidized glutathione and thymine glycol formation. In addition, the radical buffering capacity of these cells was significantly compromised within 7 h of treatment with rhTNF. The P388 and Pan-02 cell lines, with total glutathione levels about 50-fold higher than L929, also showed evidence of oxidative attack, although to a lesser extent than L929. The radical buffering capacity of these cell lines was not altered by rhTNF treatment. A rhTNF-resistant subline of L929 (L929r), produced by successive passaging in vitro in the presence of TNF, increased its glutathione and oxidized glutathione levels in response to a subsequent rhTNF challenge. Meth A, a cell line resistant to rhTNF in vitro but not in vivo, showed no evidence of oxidative damage following rhTNF treatment, despite having a low radical scavenging capacity and a sensitivity to H2O2. The results with Meth A suggest that the interaction of rhTNF with this cell line does not occur in the same manner as the other cell lines, perhaps due to receptor differences or to some type of "uncoupling" of the signal-response network between the TNF receptor and a putative secondary messenger(s). These results are consistent with the hypothesis that: (a) the mechanism of action of rhTNF involves the production of oxidative damage, including damage to the DNA; (b) the sensitivity to rhTNF in vitro is related to the radical scavenging capacity of the cell; and (c) cells can respond to rhTNF challenge by increasing their free radical scavenging capacity.

1 This work was supported in part by USPHS Grant CA 40453 awarded by the National Cancer Institute, Department of Health and Human Services, and by the Office of Health and Environmental Research, Office of Energy Research, United States Department of Energy Contract DE-AC03-76SF00098.

2 To whom requests for reprints should be addressed, at Cetus Corporation, 1400 53rd Street, Emeryville, CA 94608.

Received 8/31/88. Revised 12/12/88. Accepted 1/ 5/89.




This article has been cited by other articles:


Home page
FASEB J.Home page
H.-M. Shen and S. Pervaiz
TNF receptor superfamily-induced cell death: redox-dependent execution
FASEB J, August 1, 2006; 20(10): 1589 - 1598.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. He and H. E. P. Bazan
Synergistic Effect of Platelet-Activating Factor and Tumor Necrosis Factor-{alpha} on Corneal Myofibroblast Apoptosis.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 883 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sugino, A. Karube-Harada, A. Sakata, S. Takiguchi, and H. Kato
Nuclear Factor-{kappa}B Is Required for Tumor Necrosis Factor-{alpha}-Induced Manganese Superoxide Dismutase Expression in Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3845 - 3850.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Karube-Harada, N. Sugino, S. Kashida, S. Takiguchi, H. Takayama, Y. Yamagata, Y. Nakamura, and H. Kato
Induction of manganese superoxide dismutase by tumour necrosis factor-{alpha} in human endometrial stromal cells
Mol. Hum. Reprod., November 1, 2001; 7(11): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. M. Siemankowski, J. Morreale, B. D. Butts, and M. M. Briehl
Increased Tumor Necrosis Factor-{{alpha}} Sensitivity of MCF-7 Cells Transfected with NAD(P)H:Quinone Reductase
Cancer Res., July 1, 2000; 60(13): 3638 - 3644.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
N. Sugino, S. Kashida, S. Takiguchi, Y. Nakamura, and H. Kato
Induction of superoxide dismutase by decidualization in human endometrial stromal cells
Mol. Hum. Reprod., February 1, 2000; 6(2): 178 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Petrache, L. E. Otterbein, J. Alam, G. W. Wiegand, and A. M. K. Choi
Heme oxygenase-1 inhibits TNF-alpha -induced apoptosis in cultured fibroblasts
Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L312 - L319.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. Ratter, C. Gaßner, V. Shatrov, and V. Lehmann
Modulation of tumor necrosis factor-{alpha}-mediated cytotoxicity by changes of the cellular methylation state: mechanism and in vivo relevance
Int. Immunol., April 1, 1999; 11(4): 519 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Gotoh and J. A. Cooper
Reactive Oxygen Species- and Dimerization-induced Activation of Apoptosis Signal-regulating Kinase 1 in Tumor Necrosis Factor-alpha Signal Transduction
J. Biol. Chem., July 10, 1998; 273(28): 17477 - 17482.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Shirafuji, S. Takahashi, S. Matsuda, and S. Asano
Mitochondrial Antisense RNA for Cytochrome C Oxidase (MARCO) Can Induce Morphologic Changes and Cell Death in Human Hematopoietic Cell Lines
Blood, December 1, 1997; 90(11): 4567 - 4577.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Pastorino, G. Simbula, K. Yamamoto, P. A. Glascott Jr., R. J. Rothman, and J. L. Farber
The Cytotoxicity of Tumor Necrosis Factor Depends on Induction of the Mitochondrial Permeability Transition
J. Biol. Chem., November 22, 1996; 271(47): 29792 - 29798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Bai and A. I. Cederbaum
Overexpression of Catalase in the Mitochondrial or Cytosolic Compartment Increases Sensitivity of HepG2 Cells to Tumor Necrosis Factor-alpha -induced Apoptosis
J. Biol. Chem., June 16, 2000; 275(25): 19241 - 19249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.